Avelumab: New Agent Available for Merkel Cell Carcinoma

aacr2017 has 92 videos Subscribe Here

Description: Howard L. Kaufman, MD, FACS of Rutgers Cancer Institute of New Jersey discusses the use of avelumab, a new agent that became available for patients with merkel cell carcinoma. This was recorded at the American Association for Cancer Research (AACR) 2017 Annual Meeting in Washington, DC.
Shared By : aacr2017
Posted on : 04/27/17
Added : 7 months ago


Nothing found.

More From aacr2017

Nothing found.